-
-
Safety,Quality,Efficacy -
Safety,Quality,Efficacy -
Safety,Quality,Efficacy
Provide users with high-quality blood products
-
2023/03/01Shanghai RAAS was re-awarded the title of "Leading Enterprise of Oriental Beauty Valley".View Details
-
2022/10/21"Excellent! They are "Shanghai Pioneer Workers"View Details
-
-
2022/10/21Congratulations on the official release of the Blue Book on the Development and Clinical Application of Blood Products in China!
-
2022/05/05Shanghai RAAS Becomes the Exclusive Distributor of Grifols Nucleic Acid Testing Solution in China
-
2022/02/14ShanghaiRAAS was awarded the title of "Leading Enterprise of Oriental Beauty Valley"
-
About RAAS
Being vital for life saving, blood products are important national strategic reserve materials. Founded in 1988 and situated at No. 2009 Wangyuan Road, Fengxian District, Shanghai with a registered capital of RMB 6,740,787,907.00, Shanghai RAAS was listed on the Shenzhen Stock Exchange in June 2008 as a leading domestic blood products company that integrates source plasma collection, blood products research and development, production and sales.
-
35 years Extensive industry experience
-
4 units Production Bases
-
42 centers (including newly approved) Plasma Donation Center
+0.20 (+3.13%)
RAAS Plasma Donation Center
As of May 2023, Shanghai RAAS and its subsidiaries had 42 plasma donation centers (including newly approved ) in China including those under construction, of which 18 are Shanghai RAAS (including one subcenter) , 19 are Tonrol Biopharmaceutical (including newly approved) , 2 are Zhengzhou RAAS and 3 are Zhejiang Haikang Biopharmaceutical, covering 11 provinces (autonomous regions) in Guangxi, Hunan, Hainan, Shaanxi, Anhui, Guangdong, Inner Mongolia, Zhejiang, Hubei, Jiangxi and Shandong.
-
18 centers Shanghai RAAS (including one subcenter)
-
19 centers Tonrol Biopharmaceutical
-
2 centers Zhengzhou RAAS
-
3 centers Zhejiang Haikang Biopharmaceutical
